93 related articles for article (PubMed ID: 22592160)
1. T-Cadherin is an auxiliary negative regulator of EGFR pathway activity in cutaneous squamous cell carcinoma: impact on cell motility.
Kyriakakis E; Maslova K; Philippova M; Pfaff D; Joshi MB; Buechner SA; Erne P; Resink TJ
J Invest Dermatol; 2012 Sep; 132(9):2275-85. PubMed ID: 22592160
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts.
Kyriakakis E; Maslova K; Frachet A; Ferri N; Contini A; Pfaff D; Erne P; Resink TJ; Philippova M
Cell Signal; 2013 May; 25(5):1044-53. PubMed ID: 23411345
[TBL] [Abstract][Full Text] [Related]
3. T-cadherin loss promotes experimental metastasis of squamous cell carcinoma.
Philippova M; Pfaff D; Kyriakakis E; Buechner SA; Iezzi G; Spagnoli GC; Schoenenberger AW; Erne P; Resink TJ
Eur J Cancer; 2013 May; 49(8):2048-58. PubMed ID: 23369463
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical effects of T-cadherin on squamous cell carcinoma: up- and down-regulation increase xenograft growth by distinct mechanisms.
Pfaff D; Philippova M; Kyriakakis E; Maslova K; Rupp K; Buechner SA; Iezzi G; Spagnoli GC; Erne P; Resink TJ
J Pathol; 2011 Dec; 225(4):512-24. PubMed ID: 21766307
[TBL] [Abstract][Full Text] [Related]
5. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
6. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
[TBL] [Abstract][Full Text] [Related]
7. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
Mukoyama Y; Utani A; Matsui S; Zhou S; Miyachi Y; Matsuyoshi N
Genes Cells; 2007 Jun; 12(6):787-96. PubMed ID: 17573778
[TBL] [Abstract][Full Text] [Related]
8. T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo.
Pfaff D; Philippova M; Buechner SA; Maslova K; Mathys T; Erne P; Resink TJ
Br J Dermatol; 2010 Aug; 163(2):353-63. PubMed ID: 20394625
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
11. Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
Lichtner RB; Menrad A; Sommer A; Klar U; Schneider MR
Cancer Res; 2001 Aug; 61(15):5790-5. PubMed ID: 11479217
[TBL] [Abstract][Full Text] [Related]
12. EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin.
Maslova K; Kyriakakis E; Pfaff D; Frachet A; Frismantiene A; Bubendorf L; Ruiz C; Vlajnic T; Erne P; Resink TJ; Philippova M
FASEB J; 2015 Feb; 29(2):494-507. PubMed ID: 25381040
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells.
Matheny KE; Barbieri CE; Sniezek JC; Arteaga CL; Pietenpol JA
Laryngoscope; 2003 Jun; 113(6):936-9. PubMed ID: 12782800
[TBL] [Abstract][Full Text] [Related]
14. AEE788, a dual tyrosine kinase receptor inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice.
Park YW; Younes MN; Jasser SA; Yigitbasi OG; Zhou G; Bucana CD; Bekele BN; Myers JN
Clin Cancer Res; 2005 Mar; 11(5):1963-73. PubMed ID: 15756022
[TBL] [Abstract][Full Text] [Related]
15. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells.
Philippova M; Joshi MB; Pfaff D; Kyriakakis E; Maslova K; Erne P; Resink TJ
Cardiovasc Res; 2012 Mar; 93(3):498-507. PubMed ID: 22235028
[TBL] [Abstract][Full Text] [Related]
16. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
[TBL] [Abstract][Full Text] [Related]
17. Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells.
Andersen H; Mejlvang J; Mahmood S; Gromova I; Gromov P; Lukanidin E; Kriajevska M; Mellon JK; Tulchinsky E
Mol Cell Biol; 2005 Oct; 25(20):9138-50. PubMed ID: 16199889
[TBL] [Abstract][Full Text] [Related]
18. T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells.
Mukoyama Y; Zhou S; Miyachi Y; Matsuyoshi N
J Invest Dermatol; 2005 Apr; 124(4):833-8. PubMed ID: 15816843
[TBL] [Abstract][Full Text] [Related]
19. Rab23 promotes squamous cell carcinoma cell migration and invasion via integrin β1/Rac1 pathway.
Jian Q; Miao Y; Tang L; Huang M; Yang Y; Ba W; Liu Y; Chi S; Li C
Oncotarget; 2016 Feb; 7(5):5342-52. PubMed ID: 26716504
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Notch1 and its potential correlation with epidermal growth factor receptor signalling in tongue squamous cell carcinoma.
Huang HJ; Ping FY; Hu JA; Zhao SF
Br J Oral Maxillofac Surg; 2010 Jan; 48(1):30-6. PubMed ID: 19398252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]